Search clinical trials for: Fibrinolytic Agents

Total 187935 results

Hallym University Medical Center

Unknown

4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock

Severe Sepsis
CSL Behring

Completed

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Factor XIII Deficiency

United States
Assiut University

Not yet recruiting

Impact of Antenatal Steroids on Coagulation.

Corticosteroids Adverse Reaction
Oslo University Hospital
University of Oslo

Active, not recruiting

The Effect of the CytoSorb® Filter to Remove Anticoagulants From the Circulation During Emergency Surgery for Aortic Dissection (Citron)

Aortic Dissection | Factor X Inhibition

Norway
Ain Shams University

Completed

Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

Sepsis | HBP

Egypt
University of Missouri-Columbia
Eskisehir Osmangazi University Training and Research Hospital; Kartal Dr. Lütfi... and other collaborators

Completed

Endovascular Stroke Treatment Only (ESTO) Trial

Acute Ischemic Stroke

United States
Vestre Viken Hospital Trust

Terminated

Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture (thro-fract15)

Thromboembolism

Norway
Federal Center of Cerebrovascular Pathology and...

Unknown

Russian Prospective Multicenter Registry Study of Intravenous Thrombolytic Therapy for Acute Ischemic Stroke (IVT-AIS-R)

The Aim the Study is to Collect and Analyze Data on Patients With Acute Ischemic Stroke During Intravenous Thrombolytic Therapy With Alteplase

Russian Federation
Centre hospitalier de l'Université de Montréal...

Completed

Evaluation Of Enoxaparin Pharmacokinetic For Thromboprophylaxis In Burn Care Patients

Skin Burn Extensive

Canada
Ege University

Completed

As an Early Indicator Biomarker of Prognosis and Mortality in Children With Sepsis and Septic Shock: suPAR (suPAR)

Septic Shock | Sepsis, Severe

Turkey
University Hospital of North Norway
Nordlandssykehuset HF

Terminated

Telestroke in Nordland Hospital. A Study of a Telemedicine Network in Rural Hospitals (Telestroke)

Stroke, Acute

Norway
Axis Shield Diagnostics Ltd

Terminated

Sepsis Assessment in Belgian Emergency Rooms (SABER)

Sepsis | Shock, Septic | Severe Sepsis

Belgium
Dr. Vicky Tagalakis
Sanofi

Terminated

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots (STEP-CAT)

Deep Vein Thrombosis

Canada
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Unknown

Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism (aXa)

Neoplasms | Venous Thromboembolism

France
Axis Shield Diagnostics Ltd

Completed

IMproved PREdiction of Severe Sepsis in the Emergency Department (IMPRESSED)

Sepsis | Septic Shock | Severe Sepsis | Systemic Inflammatory Response Syndrome (SIRS)

United States, Sweden
University of Chicago
University of British Columbia

Completed

Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy

Abortion, Habitual | Recurrent Pregnancy Loss | Fetal Demise | Antiphospholipid Antibodies | Inherited Thrombophilia

United States
University Hospital, Caen

Unknown

Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke (ROTEMPredict)

Stroke

France
Centre Hospitalier Universitaire de Nīmes

Completed

The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations (NOH-ANGIO)

Antiphospholipid Syndrome

France
Ottawa Hospital Research Institute
The Ottawa Hospital

Unknown

Safety Study of Enoxaparin Prophylaxis in Critically Ill Adults With Severe Renal Insufficiency

Hemorrhage

Canada
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study (HIT-RADIO)

Heparin Induced Thrombocytopenia

United States
DSM Nutritional Products, Inc.

Completed

Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

Thromboembolic Events

Germany, United States, Switzerland
Floralis
University Hospital, Grenoble

Completed

Evaluation of the Prevention of Thromboembolic Disease in Patients With a Lower Limb Trauma, Non Surgical, in Winter Sports Resort (M2M-Thrombose)

Leg Injuries | Outpatients | Winter Sport Resorts

France
University of Saskatchewan

Completed

Heparin Dose and Post Operative Bleeding in Cardiopulmonary Bypass Patients

Coronary Artery Disease

Canada
Trio Grup Clinical Research

Unknown

Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism (TREBECA)

Venous Thromboembolism

Turkey
Emory University

Completed

Heparin Responses in Pediatric Patients Undergoing Cardiopulmonary Bypass.

Children With Heart Defects

United States
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Risk Factors for Venous Thromboembolism in the Community

Cardiovascular Diseases | Thromboembolism

United States
Johann Wolfgang Goethe University Hospital

Unknown

Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

Thrombosis | Heparin-Induced Thrombocytopenia

Germany
Centre Hospitalier Universitaire de Saint Etienne

Completed

Pharmacokinetics of Fondaparinux in Patients With Major Orthopedic Surgery (POP-A-RIX)

Orthopedic Surgery

France
Luzerner Kantonsspital
Pfizer

Completed

Pharmacokinetics of Dalteparin in Patients With Impaired Renal Function

Renal Insufficiency

Switzerland
Brigham and Women's Hospital
Sanofi

Completed

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Heparin Induced Thrombocytopenia (HIT)

United States
ARCA Biopharma, Inc.

Terminated

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Acute Ischemic Stroke

United States, Canada
ARCA Biopharma, Inc.

Completed

Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg Arteries

Arterial Occlusive Diseases

United States
Ministry of Health, Labour and Welfare, Japan

Unknown

A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients

Heparin-Induced Thrombocytopenia

Japan
PlasFree Ltd.

Recruiting

A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement

Bleeding | Bypass Complication | Valve Replacement

Israel, Czechia, Poland
Methodist Health System

Recruiting

Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

Venous Thromboembolism

United States
CytoSorbents, Inc

Recruiting

Safe and Timely Antithrombotic Removal (STAR) Registry

Blood Loss, Surgical | Blood Loss, Postoperative | Hemorrhage, Surgical | Hemorrhage Postoperative

Belgium, Germany, United Kingdom, Austria, Sweden
Centre Hospitalier Universitaire, Amiens

Recruiting

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer (PLATELETSTREAM)

Platelet Aggregation | Heparin-induced Thrombocytopenia | Platelet Activation | Platelet Disorder

France
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
Prometic Biotherapeutics, Inc.

No longer available

A Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical Trial

Hypoplasminogenemia

United States
Mylan Inc.
Winicker Norimed GmbH

Terminated

REVIparin-BRIDging-in a General Practice Setting in GErmany (REVIBRIDGE)

Thromboembolism

Germany
William Beaumont Hospitals

Completed

Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units

Covid19

United States
Dow University of Health Sciences

Unknown

Efficacy of Topical Heparin Spray on Donor Site Wound Healing Time Compared to Conventional Dressing Among Patients Undergoing Split Thickness Skin Grafting

Wound Healing

Pakistan
Masaryk Hospital Krajská zdravotní a.s.

Completed

The Prevalence and Incidence of DVT in General ICU (preTIME)

Deep Venous Thrombosis

Czechia
Hellenic Society of Surgical Oncology

Unknown

Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism

Cancer | Thromboembolism | Cancer Diagnosis

Greece
University of Medicine and Pharmacy at Ho Chi Minh...

Unknown

Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital (RARETBAS)

Stroke, Acute | Basilar Artery Occlusion
Zhujiang Hospital
Nanfang Hospital of Southern Medical University; First Affiliated Hospital...

Unknown

Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective Study

Ischemic Stroke

China
Axis Shield Diagnostics Ltd
Baylor College of Medicine; Vanderbilt University Medical Center; York Hospitals and other collaborators

Unknown

Assessment of Heparin Binding Protein for the Prediction of Severe Sepsis

Sepsis | Septic Shock | Sepsis With Acute Organ Dysfunction

United States
LEO Pharma

Completed

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

Venous Thromboembolism

France
GlaxoSmithKline

Completed

Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection

Thromboembolism
Delos Clinical

Completed

Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease

Cancer | Venous Thromboembolism | Pulmonary Thromboembolisms

3

Subscribe